...
首页> 外文期刊>癌と化学療法 >A case report of complete response by TS-1 and paclitaxel combination chemotherapy for advanced gastric cancer
【24h】

A case report of complete response by TS-1 and paclitaxel combination chemotherapy for advanced gastric cancer

机译:TS-1与紫杉醇联合化疗对晚期胃癌完全缓解的一例报告

获取原文
获取原文并翻译 | 示例

摘要

We report a case in which combination chemotherapy of TS-1 and paclitaxel was effective for gastric cancer with malignant ascites, metastatic ovarian cancer and hydronephrosis. Judging from the above issue, the stage was IV and the type was Borrmann 4. The chemotherapy schedule was adjusted at the patient' s request without hindering her activities of daily living. The patient was a 53-year-old woman who suffered from gastric cancer as having malignant ascites and metastatic ovarian tumor. As an outpatient, she was treated with combination chemotherapy of TS-1 and paclitaxel for 2 cycles. The ascites had remarkably disappeared after 2 cycles. The adverse event was alopecia (grade 2), but she could continue the chemotherapy as an outpatient treatment. After completing 5 cycles of chemotherapy, we recognized the primary tumor as an endoscopic complete response.
机译:我们报告了一个案例,其中TS-1和紫杉醇的联合化疗对伴有恶性腹水,转移性卵巢癌和肾积水的胃癌有效。从上述问题来看,阶段为IV,类型为Borrmann4。化疗方案应患者的要求进行调整,而不会影响她的日常生活。该患者是一名53岁的女性,因患有恶性腹水和转移性卵巢肿瘤而患有胃癌。作为门诊患者,她接受了TS-1和紫杉醇的联合化疗2个周期。 2个周期后,腹水已明显消失。不良事件是脱发(2级),但她可以继续化疗作为门诊治疗。完成5个周期的化疗后,我们将原发性肿瘤识别为内镜完全缓解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号